Company: TELO
Filing Date: 2025-11-20
Form Type: PREM14A
Source: 0001493152-25-024463
Chunk: 16

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-11-20
Form: PREM14A
Chunk 16
---
ger, risks and uncertainties to which the combined company’s business will be subject, and risks and uncertainties to which each of TELO and TELI, as an independent company, is subject.

Q: When do you expect the Merger to be consummated?

A:We anticipate that the Merger will be consummated during the fourth quarter of 2025, soon after the TELO Annual Meeting to be held on December 30, 2025, but we cannot predict the exact timing. For more information, please see the section titled “ The Merger

Agreement—Conditions to the Merger.”

Q: What are the material U.S. federal income tax consequences of the Merger to U.S. Holders of TELI shares?

A:TELO and TELI intend the Merger to qualify as a reorganization within the meaning of Section 368(a) of the Internal Revenue Code of 1986, as amended (the “Code”), as described in the section titled “ The Merger—Material U.S. Federal Income

Tax Consequences of the Merger.”

The tax consequences to each TELI stockholder will depend on that stockholder’s particular circumstances. Each TELI stockholder should consult with his, her or its tax advisor for a full understanding of the tax consequences of the Merger to that stockholder.

Q: What do I need to do now?

A:TELO and TELI urge you to read this proxy statement carefully, including its annexes and information incorporated herein, and to consider how the Merger affects you.

If you are a holder of TELO Common Stock as of the record date, please vote your shares as soon as possible so that your shares will be represented at the TELO Annual Meeting. Please follow the instructions set forth on the enclosed proxy card or on the voting instruction form provided by the record holder of your shares if your shares are held in the name of your bank, broker or other nominee.

Q: Am I entitled to dissenters’ rights?

A:TELO shareholders are not entitled to dissenters’ rights. See the section of this proxy statement titled “ Appraisal Rights and Dissenters’ Rights”on page 41.

Q: Am I entitled to appraisal rights?

A:TELO shareholders are not entitled to appraisal rights. See the section of this proxy statement titled “ Appraisal Rights and Dissenters’ Rights”on page 41.

Q: Have TELI’s stockholders agreed to adopt the Mer